CSI Market
Sign In | Register

Immix Biopharma Inc (IMMX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMMX Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Immix Biopharma Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent232.10
Short-term Investments, Total6.62
Cash & Short-term Investments238.00
Other Receivables6.70
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.81
Total Current Assets233.79
Equipment/Property/Plant Net2.83
Long-term investments2.05
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.43
Operating Lease Right Of Use Asset0.93
Total Assets239.11
Liabilities
Accounts Payable and Accrued Liabilities, Current LI9.19
Interest Payable, Current IN0.17
Other Liabilities, Current0.00
Total Current Liabilities9.30
Total Long-term Debt0.00
Other liabilities, Noncurrent0.89
OperatingLeaseLiabilityNoncurrent0.91
Operating Lease Liability Current0.13
Total Liabilities10.19
Stockholders' Equity
Treasury Stock Common Value-0.10
Common Stock Value0.01
Additional Paid In Capital Common Stock355.00
Retained Earnings / Accumulated Deficit-126.11
Accumulated Other Comprehensive Income0.12
Other Equity0.12
Common Stockholder's Equity228.92
Total Stockholder's Equity228.92
Liabilities & Stockholder's Equity239.11
4 historic quarters locked

Sign in to unlock the full Immix Biopharma Inc balance sheet history.

Sign In Create Free Account

About Immix Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 7, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036643

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.